ArticleMediators of inflammation2026
Association of C-Reactive Protein-Triglyceride Glucose Index With Chronic Obstructive Pulmonary Disease: Results From the NHANES and CHARLS Cohorts.
Article in Mediators of inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association of C-Reactive Protein-Triglyceride Glucose Index With Chronic Obstructive Pulmonary Disease: Results From the NHANES and CHARLS Cohorts.Mediators of inflammation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThe C-reactive protein (CRP)-triglyceride glucose index (CTI) is a new composite biomarker used to assess inflammation and insulin resistance (IR) severity. Inflammation and IR play important roles in chronic obstructive pulmonary disease (COPD). However, the impact of CTI on COPD remains unknown.
methodsTo explore the association between CTI and the prevalence of COPD, a total of 8682 participants from the China Health and Retirement Longitudinal Study (CHARLS) and 8986 participants from the US National Health and Nutrition Examination Survey (NHANES) were included. We used logistic multivariate regression to evaluate the association between CTI and COPD. In addition, smooth curve fitting analyzed dose-response relationships, while subgroup analyses explored effect heterogeneity.
resultsWe found a positive correlation between CTI and the risk of COPD after adjusting for all covariates in the NHANES database (OR = 1.34, 95% confidence interval [CI]: 1.18-1.53), which is consistent with the findings obtained from Cox regression analysis in the CHARLS database (HR = 1.16, 95% CI: 1.07-1.26), with consistent dose-response trends confirmed by restricted cubic spline (RCS) analyses. Subgroup analyses confirmed consistency across most strata, with a significant interaction detected with cardiovascular disease (CVD). Sensitivity analyses further confirmed the robustness of associations.
conclusionsThese findings indicate a significant association between CTI and COPD, suggesting its potential role as a biomarker for the prevention and treatment of COPD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.